ARCHIVES

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

Upton Says He’s Still Undecided About Leaving NCI

September 28, 1979

FDA Grants Accelerated Approval To Ferriprox for Iron Overload

October 28, 2011

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

July 25, 1975

Science Fellowships Available; Grants For Former Soviet Scientists

August 16, 1996

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014